Skip to main navigation Skip to search Skip to main content

18F-barbiturates are PET tracers with diagnostic potential in Alzheimer’s disease

  • Elisa Calamai
  • , Sergio Dall’angelo
  • , David Koss
  • , Juozas Domarkas
  • , Timothy J. McCarthy
  • , Marco Mingarelli
  • , Gernot Riedel
  • , Lutz F. Schweiger
  • , Andy Welch
  • , Bettina Platt (Lead / Corresponding author)
  • , Matteo Zanda (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Three fluoro-barbiturates were synthesised, showing in vivo sedative efficacy. One of them, [18F]1a, was synthesised in radiofluorinated form. PET/CT Imaging with [18F]1a identified β-amyloid over-expressing transgenic mice (βA mice) compared to wild type and tau lines. The fluorescent barbiturate 9 was able to label βA plaques in brain sections of βA mice, and co-localise with a fluorescent Zn(II) indicator.

    Original languageEnglish
    Pages (from-to)792-794
    Number of pages3
    JournalChemical Communications
    Volume49
    Issue number8
    Early online date4 Dec 2012
    DOIs
    Publication statusPublished - 2013

    ASJC Scopus subject areas

    • Catalysis
    • Electronic, Optical and Magnetic Materials
    • Ceramics and Composites
    • General Chemistry
    • Surfaces, Coatings and Films
    • Metals and Alloys
    • Materials Chemistry

    Fingerprint

    Dive into the research topics of '18F-barbiturates are PET tracers with diagnostic potential in Alzheimer’s disease'. Together they form a unique fingerprint.

    Cite this